{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"0"}]}],"title":"Nausea"},{"categories":[{"measurements":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"}]}],"title":"Vomiting"},{"categories":[{"measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"0"}]}],"title":"Constipation"},{"categories":[{"measurements":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}],"title":"Anorexia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"15"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"0"}]}],"title":"Fatigue"},{"categories":[{"measurements":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}],"title":"Neutropenia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"44"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}],"title":"Thrombocytopenia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"1"}]}],"title":"Anemia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"}]}],"title":"Cardiovascular"},{"categories":[{"measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"}]}],"title":"Neuropathy (sensory)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"0"}]}],"title":"Other neurologic"},{"categories":[{"measurements":[{"groupId":"OG000","value":"39"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}],"title":"Dermatologic"},{"categories":[{"measurements":[{"groupId":"OG000","value":"40"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"0"}]}],"title":"Metabolic"},{"categories":[{"measurements":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"}]}],"title":"Pain"}],"denoms":[{"counts":[{"groupId":"OG000","value":"45"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"45"},{"groupId":"OG004","value":"45"}],"units":"Participants"}],"groups":[{"description":"Number of patients who did not experience the adverse event.","id":"OG000","title":"Grade 0"},{"description":"Number of patients who experienced a Grade 1 adverse event (Common Toxicity Criteria version 2)","id":"OG001","title":"Grade 1"},{"description":"Number of patients who experienced a Grade 2 adverse event (Common Toxicity Criteria version 2)","id":"OG002","title":"Grade 2"},{"description":"Number of patients who experienced a Grade 3 adverse event (Common Toxicity Criteria version 2)","id":"OG003","title":"Grade 3"},{"description":"Number of patients who experienced a Grade 4 adverse event (Common Toxicity Criteria version 2)","id":"OG004","title":"Grade 4"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Eligible and evaluable patients","reportingStatus":"POSTED","timeFrame":"Each cycle during treatment and 30 days after the last treatment (average 4 months)","title":"Frequency and Severity of Adverse Effects as Assessed by Common Toxicity Criteria (CTC) v2.0","type":"PRIMARY","unitOfMeasure":"Participants"}